A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma

NCT07472790 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

High-grade Glioma

Interventions

BIOLOGICAL: Novel oncolytic virus Ad-TD-nsIL12（BioTTT001）

Sponsor

Beijing Bio-Targeting Therapeutics Technology Co., Ltd